Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 45


Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE.

Kim D, Mebius RE, MacMicking JD, Jung S, Cupedo T, Castellanos Y, Rho J, Wong BR, Josien R, Kim N, Rennert PD, Choi Y.

J Exp Med. 2000 Nov 20;192(10):1467-78.


Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor.

Kaneda T, Nojima T, Nakagawa M, Ogasawara A, Kaneko H, Sato T, Mano H, Kumegawa M, Hakeda Y.

J Immunol. 2000 Oct 15;165(8):4254-63.


Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.

Michigami T, Shimizu N, Williams PJ, Niewolna M, Dallas SL, Mundy GR, Yoneda T.

Blood. 2000 Sep 1;96(5):1953-60.


Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice.

Tagaya H, Kunisada T, Yamazaki H, Yamane T, Tokuhisa T, Wagner EF, Sudo T, Shultz LD, Hayashi SI.

Blood. 2000 Jun 1;95(11):3363-70.


Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord.

Honore P, Luger NM, Sabino MA, Schwei MJ, Rogers SD, Mach DB, O'keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW.

Nat Med. 2000 May;6(5):521-8. Erratum in: Nat Med 2000 Jul;6(7):838.


Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy.

Capparelli C, Kostenuik PJ, Morony S, Starnes C, Weimann B, Van G, Scully S, Qi M, Lacey DL, Dunstan CR.

Cancer Res. 2000 Feb 15;60(4):783-7.


Signaling inputs converge on nuclear effectors in TGF-beta signaling.

ten Dijke P, Miyazono K, Heldin CH.

Trends Biochem Sci. 2000 Feb;25(2):64-70. Review.


Transforming growth factor beta from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes.

Cook G, Campbell JD, Carr CE, Boyd KS, Franklin IM.

J Leukoc Biol. 1999 Dec;66(6):981-8.


Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease.

Hjertner O, Torgersen ML, Seidel C, Hjorth-Hansen H, Waage A, Børset M, Sundan A.

Blood. 1999 Dec 1;94(11):3883-8.


RANK is essential for osteoclast and lymph node development.

Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J.

Genes Dev. 1999 Sep 15;13(18):2412-24.


Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism.

Hofbauer LC.

Eur J Endocrinol. 1999 Sep;141(3):195-210. Review. No abstract available.


A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.

Morony S, Capparelli C, Lee R, Shimamoto G, Boone T, Lacey DL, Dunstan CR.

J Bone Miner Res. 1999 Sep;14(9):1478-85.


Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption.

Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, Tanne K, Maeda N, Nishikawa S, Kodama H.

J Exp Med. 1999 Jul 19;190(2):293-8.


Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.

Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T.

J Immunol. 1999 Jul 1;163(1):434-42.


Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival.

Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlöndorff J, Tempst P, Choi Y, Blobel CP.

J Biol Chem. 1999 May 7;274(19):13613-8.


Homing mechanisms of myeloma cells.

Van Riet I.

Pathol Biol (Paris). 1999 Feb;47(2):98-108. Review.


OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.

Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM.

Nature. 1999 Jan 28;397(6717):315-23.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk